Cargando…

Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021

Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaohan, Li, Yuanyuan, Tang, Yuan, Li, Zhiyu, Wang, Sanfeng, Luo, Xiping, He, Tianwen, Yin, Aihua, Luo, Mingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936994/
https://www.ncbi.nlm.nih.gov/pubmed/36744409
http://dx.doi.org/10.1080/22221751.2023.2176009
_version_ 1784890339979427840
author Yang, Xiaohan
Li, Yuanyuan
Tang, Yuan
Li, Zhiyu
Wang, Sanfeng
Luo, Xiping
He, Tianwen
Yin, Aihua
Luo, Mingyong
author_facet Yang, Xiaohan
Li, Yuanyuan
Tang, Yuan
Li, Zhiyu
Wang, Sanfeng
Luo, Xiping
He, Tianwen
Yin, Aihua
Luo, Mingyong
author_sort Yang, Xiaohan
collection PubMed
description Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who underwent routine cervical screening were investigated from 2015 to 2021 in Guangzhou, south China. The results showed that the overall HPV prevalence was 21.66% (42,911/198,111), and the annual prevalence increased significantly from 2015 to 2021 (p < 0.001). HPV52, 16, 58, CP8304, 51, 53, 39, and 68 were the most prevalent HPV types. The relative HPV-positive rate correlated positively with the progression of cervical intraepithelial neoplasia (p < 0.001); HPV16 was the predominant carcinogenic type, followed by HPV52 and HPV18. HPV infections were significantly age-specific, and 26.51% (11,375/42,911) of cases were caused by multiple HPV types. In addition, HPV infections typically cleared over a median time of 16 (interquartile range 9–31) months, and the clearance of HPV16 was significantly faster than that of other types (p < 0.001). These findings may serve as a guide for local governments to evaluate HPV vaccination and cervical cancer prevention strategies in south China.
format Online
Article
Text
id pubmed-9936994
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-99369942023-02-18 Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021 Yang, Xiaohan Li, Yuanyuan Tang, Yuan Li, Zhiyu Wang, Sanfeng Luo, Xiping He, Tianwen Yin, Aihua Luo, Mingyong Emerg Microbes Infect Research Article Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who underwent routine cervical screening were investigated from 2015 to 2021 in Guangzhou, south China. The results showed that the overall HPV prevalence was 21.66% (42,911/198,111), and the annual prevalence increased significantly from 2015 to 2021 (p < 0.001). HPV52, 16, 58, CP8304, 51, 53, 39, and 68 were the most prevalent HPV types. The relative HPV-positive rate correlated positively with the progression of cervical intraepithelial neoplasia (p < 0.001); HPV16 was the predominant carcinogenic type, followed by HPV52 and HPV18. HPV infections were significantly age-specific, and 26.51% (11,375/42,911) of cases were caused by multiple HPV types. In addition, HPV infections typically cleared over a median time of 16 (interquartile range 9–31) months, and the clearance of HPV16 was significantly faster than that of other types (p < 0.001). These findings may serve as a guide for local governments to evaluate HPV vaccination and cervical cancer prevention strategies in south China. Taylor & Francis 2023-02-15 /pmc/articles/PMC9936994/ /pubmed/36744409 http://dx.doi.org/10.1080/22221751.2023.2176009 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Xiaohan
Li, Yuanyuan
Tang, Yuan
Li, Zhiyu
Wang, Sanfeng
Luo, Xiping
He, Tianwen
Yin, Aihua
Luo, Mingyong
Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title_full Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title_fullStr Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title_full_unstemmed Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title_short Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021
title_sort cervical hpv infection in guangzhou, china: an epidemiological study of 198,111 women from 2015 to 2021
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936994/
https://www.ncbi.nlm.nih.gov/pubmed/36744409
http://dx.doi.org/10.1080/22221751.2023.2176009
work_keys_str_mv AT yangxiaohan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT liyuanyuan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT tangyuan cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT lizhiyu cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT wangsanfeng cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT luoxiping cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT hetianwen cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT yinaihua cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021
AT luomingyong cervicalhpvinfectioninguangzhouchinaanepidemiologicalstudyof198111womenfrom2015to2021